Get the Stockscreener App
0.8567
0.19%
0.0016
After Hours:
.86
0.0033
+0.39%
Femasys Inc stock is traded at $0.8567, with a volume of 760.18K.
It is up +0.19% in the last 24 hours and down -10.97% over the past month.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
See More
Previous Close:
$0.8551
Open:
$0.8551
24h Volume:
760.18K
Relative Volume:
0.10
Market Cap:
$50.10M
Revenue:
$950.10K
Net Income/Loss:
$-16.69M
P/E Ratio:
-1.0322
EPS:
-0.83
Net Cash Flow:
$-15.16M
1W Performance:
-2.65%
1M Performance:
-10.97%
6M Performance:
-7.38%
1Y Performance:
-28.01%
1-Day Range:
$0.845
$0.89
1-Week Range:
$0.7921
$0.9097
52-Week Range:
$0.3067
$1.80
Femasys Inc Stock (FEMY) Company Profile
Name
Femasys Inc
Sector
Industry
Phone
770-500-3910
Address
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.8567 | 50.01M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
Femasys Inc Stock (FEMY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-25 | Initiated | Laidlaw | Buy |
Femasys Inc Stock (FEMY) Latest News
Femasys Secures Major Order for FemBloc Launch - MSN
FDA Approves Final Trial Phase for Femasys’ Permanent Birth Control Product - Medical Product Outsourcing
PharmaCyte’s Successful Stake Earns them Millions - StocksToTrade
PharmaCyte Boosts Financial Position with Femasys Stake Sale - timothysykes.com
PMCB Stock Jumps 25% After Company Sells Stake In Femasys - MSN
Femasys Inc Stock Analysis and ForecastTechnical Breakout Signals & Minimal Capital Trading - earlytimes.in
CapEx per share of Femasys Inc. – NASDAQ:FEMY - TradingView
Femasys (NASDAQ:FEMY) Rating Increased to Hold at Wall Street Zen - MarketBeat
PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN
Why Femasys Inc. stock is a must watch in 20252025 Earnings Impact & High Return Trade Guides - BỘ NỘI VỤ
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million - Investing.com Nigeria
PharmaCyte Biotech stock soars after successful Femasys stake sale By Investing.com - Investing.com Australia
PharmaCyte Biotech stock soars after successful Femasys stake sale - Investing.com India
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment - Lelezard
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million By Investing.com - Investing.com South Africa
PharmaCyte Biotech (Nasdaq: PMCB) Now Holds ~$20M Cash, $25M in Marketable Securities - Stock Titan
Femasys Inc. (FEMY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Femasys (FEMY) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential By Investing.com - Investing.com South Africa
Femasys initiated with a Buy at Laidlaw - TipRanks
Why retail investors pile into Femasys Inc. stockJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com
Is Femasys Inc. stock oversold or undervaluedJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential - Investing.com
Is Femasys Inc. stock attractive for growth ETFsEarnings Summary Report & Safe Capital Growth Stock Tips - newser.com
What margin trends mean for Femasys Inc. stockRate Hike & Fast Exit Strategy with Risk Control - newser.com
Is Femasys Inc. stock affected by interest rate hikesInsider Buying & Verified Entry Point Detection - newser.com
[Form 4] FEMASYS INC Insider Trading Activity - Stock Titan
Applying Elliott Wave Theory to Femasys Inc.2025 Geopolitical Influence & Fast Entry Momentum Alerts - newser.com
Femasys: Strategic Advancements and Financial Health Justify Buy Rating - TipRanks
MSN Money - MSN
Can Femasys Inc. stock reach $100 price targetMarket Risk Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Is Femasys Inc. trending in predictive chart modelsJuly 2025 Levels & Weekly High Momentum Picks - newser.com
Custom watchlist performance reports with Femasys Inc.Earnings Growth Summary & Daily Entry Point Trade Alerts - newser.com
Is Femasys Inc. stock a safe haven assetMarket Performance Report & Reliable Entry Point Alerts - newser.com
Femasys Inc Stock (FEMY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):